Wikimedia, Tom VarcoThe US Food and Drug Administration (FDA) approved 35 innovative new drugs in the fiscal year that ended September 30, 2012, one of the highest totals in recent years, according to a report released by the agency this week (December 5).
The total matches that of last year, and is the highest it’s been since 2004, when 36 new medicines were passed. In the intervening years, the number fell to little more than half its current level. Because drug approvals often reflect the number of applications filed in the previous year, the report may be indicative of a healthier and more productive pharmaceutical industry.
The FDA claims that the figures also reflect improvements in its approval process. “Most of the drugs were approved for US patients before they were available in other countries, and the efficiency of the drug review process continued to grow,” the report read. Indeed, of the 32 drugs also approved in other countries, 24 were first approved in the U.S., and 77 ...
